Niall Martin is the founder of Artios Pharma. Artios Pharma has raised $186M in total funding. Latest round: Series C. Based in Cambridge, null.
Niall Martin is a biotech executive associated with Artios Pharma, a Cambridge-based company focused on DNA damage response cancer therapeutics. He served as CEO of Artios Pharma in 2016 and 2021 before being replaced by Michael Andriole. He has been recognized in biotech media for his contributions to the company's development.
Full founder directory · Investor directory · Company funding database · Fundraising library